New Clinical Data from Aura Biosciences to be Featured in Presentation at the American Academy of Ophthalmology 2017 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--#aao2017--Aura Biosciences announced today that Carol Shields, M.D., will present data from the Phase 1b clinical safety study of AU-011 at AAO.